Natural history of stage I non-small cell lung cancer: Implications for early detection

Dan J. Raz, Jason A. Zell, S. H Ignatius Ou, David R Gandara, Hoda Anton-Culver, David M. Jablons

Research output: Contribution to journalArticle

203 Citations (Scopus)

Abstract

Background: Concern has been raised that early detection of lung cancer may lead to the treatment of clinically indolent cancers. No population-based study has examined the natural history of patients with stage I NSCLC who receive no surgery, chemotherapy, or radiation therapy. Our hypothesis is that long-term survival in patients with untreated stage I non-small cell lung cancer (NSCLC) is uncommon. Methods: A total of 101,844 incident cases of NSCLC in the California Cancer Center registry between 1989 and 2003 were analyzed; 19,702 patients had stage I disease, of whom 1,432 did not undergo surgical resection or receive treatment with chemotherapy or radiation. Five-year overall survival (OS) and lung cancer-specific survival were determined for this untreated group, for subsets of patients who were recommended but refused surgical resection, and for T1 tumors. Results: Only 42 patients with untreated stage I NSCLC were alive 5 years after diagnosis. Five-year OS for untreated stage I NSCLC was 6% overall, 9% for T1 tumors, and 11% for patients who refused surgical resection. Five-year lung cancer-specific survival rates were 16%, 23%, and 22%, respectively. Among these untreated patients, median survival was 9 months overall, 13 months for patients with T1 disease, and 14 months for patients who refused surgical resection. Conclusion: Long-term survival with untreated stage I NSCLC is uncommon, and the vast majority of untreated patients die of lung cancer. Given that median survival is only 13 months in patients with T1 disease, surgical resection or other ablative therapies should not be delayed even in patients with small lung cancers.

Original languageEnglish (US)
Pages (from-to)193-199
Number of pages7
JournalChest
Volume132
Issue number1
DOIs
StatePublished - Jul 2007

Fingerprint

Natural History
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Survival
Neoplasms
Drug Therapy
Early Detection of Cancer
Registries
Radiotherapy
Therapeutics
Survival Rate
Radiation

Keywords

  • Early detection
  • Non-small cell lung cancer
  • Screening
  • Survival

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Raz, D. J., Zell, J. A., Ou, S. H. I., Gandara, D. R., Anton-Culver, H., & Jablons, D. M. (2007). Natural history of stage I non-small cell lung cancer: Implications for early detection. Chest, 132(1), 193-199. https://doi.org/10.1378/chest.06-3096

Natural history of stage I non-small cell lung cancer : Implications for early detection. / Raz, Dan J.; Zell, Jason A.; Ou, S. H Ignatius; Gandara, David R; Anton-Culver, Hoda; Jablons, David M.

In: Chest, Vol. 132, No. 1, 07.2007, p. 193-199.

Research output: Contribution to journalArticle

Raz, DJ, Zell, JA, Ou, SHI, Gandara, DR, Anton-Culver, H & Jablons, DM 2007, 'Natural history of stage I non-small cell lung cancer: Implications for early detection', Chest, vol. 132, no. 1, pp. 193-199. https://doi.org/10.1378/chest.06-3096
Raz, Dan J. ; Zell, Jason A. ; Ou, S. H Ignatius ; Gandara, David R ; Anton-Culver, Hoda ; Jablons, David M. / Natural history of stage I non-small cell lung cancer : Implications for early detection. In: Chest. 2007 ; Vol. 132, No. 1. pp. 193-199.
@article{eec0a2f934e54ab5950bd3b6e43fe89d,
title = "Natural history of stage I non-small cell lung cancer: Implications for early detection",
abstract = "Background: Concern has been raised that early detection of lung cancer may lead to the treatment of clinically indolent cancers. No population-based study has examined the natural history of patients with stage I NSCLC who receive no surgery, chemotherapy, or radiation therapy. Our hypothesis is that long-term survival in patients with untreated stage I non-small cell lung cancer (NSCLC) is uncommon. Methods: A total of 101,844 incident cases of NSCLC in the California Cancer Center registry between 1989 and 2003 were analyzed; 19,702 patients had stage I disease, of whom 1,432 did not undergo surgical resection or receive treatment with chemotherapy or radiation. Five-year overall survival (OS) and lung cancer-specific survival were determined for this untreated group, for subsets of patients who were recommended but refused surgical resection, and for T1 tumors. Results: Only 42 patients with untreated stage I NSCLC were alive 5 years after diagnosis. Five-year OS for untreated stage I NSCLC was 6{\%} overall, 9{\%} for T1 tumors, and 11{\%} for patients who refused surgical resection. Five-year lung cancer-specific survival rates were 16{\%}, 23{\%}, and 22{\%}, respectively. Among these untreated patients, median survival was 9 months overall, 13 months for patients with T1 disease, and 14 months for patients who refused surgical resection. Conclusion: Long-term survival with untreated stage I NSCLC is uncommon, and the vast majority of untreated patients die of lung cancer. Given that median survival is only 13 months in patients with T1 disease, surgical resection or other ablative therapies should not be delayed even in patients with small lung cancers.",
keywords = "Early detection, Non-small cell lung cancer, Screening, Survival",
author = "Raz, {Dan J.} and Zell, {Jason A.} and Ou, {S. H Ignatius} and Gandara, {David R} and Hoda Anton-Culver and Jablons, {David M.}",
year = "2007",
month = "7",
doi = "10.1378/chest.06-3096",
language = "English (US)",
volume = "132",
pages = "193--199",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "1",

}

TY - JOUR

T1 - Natural history of stage I non-small cell lung cancer

T2 - Implications for early detection

AU - Raz, Dan J.

AU - Zell, Jason A.

AU - Ou, S. H Ignatius

AU - Gandara, David R

AU - Anton-Culver, Hoda

AU - Jablons, David M.

PY - 2007/7

Y1 - 2007/7

N2 - Background: Concern has been raised that early detection of lung cancer may lead to the treatment of clinically indolent cancers. No population-based study has examined the natural history of patients with stage I NSCLC who receive no surgery, chemotherapy, or radiation therapy. Our hypothesis is that long-term survival in patients with untreated stage I non-small cell lung cancer (NSCLC) is uncommon. Methods: A total of 101,844 incident cases of NSCLC in the California Cancer Center registry between 1989 and 2003 were analyzed; 19,702 patients had stage I disease, of whom 1,432 did not undergo surgical resection or receive treatment with chemotherapy or radiation. Five-year overall survival (OS) and lung cancer-specific survival were determined for this untreated group, for subsets of patients who were recommended but refused surgical resection, and for T1 tumors. Results: Only 42 patients with untreated stage I NSCLC were alive 5 years after diagnosis. Five-year OS for untreated stage I NSCLC was 6% overall, 9% for T1 tumors, and 11% for patients who refused surgical resection. Five-year lung cancer-specific survival rates were 16%, 23%, and 22%, respectively. Among these untreated patients, median survival was 9 months overall, 13 months for patients with T1 disease, and 14 months for patients who refused surgical resection. Conclusion: Long-term survival with untreated stage I NSCLC is uncommon, and the vast majority of untreated patients die of lung cancer. Given that median survival is only 13 months in patients with T1 disease, surgical resection or other ablative therapies should not be delayed even in patients with small lung cancers.

AB - Background: Concern has been raised that early detection of lung cancer may lead to the treatment of clinically indolent cancers. No population-based study has examined the natural history of patients with stage I NSCLC who receive no surgery, chemotherapy, or radiation therapy. Our hypothesis is that long-term survival in patients with untreated stage I non-small cell lung cancer (NSCLC) is uncommon. Methods: A total of 101,844 incident cases of NSCLC in the California Cancer Center registry between 1989 and 2003 were analyzed; 19,702 patients had stage I disease, of whom 1,432 did not undergo surgical resection or receive treatment with chemotherapy or radiation. Five-year overall survival (OS) and lung cancer-specific survival were determined for this untreated group, for subsets of patients who were recommended but refused surgical resection, and for T1 tumors. Results: Only 42 patients with untreated stage I NSCLC were alive 5 years after diagnosis. Five-year OS for untreated stage I NSCLC was 6% overall, 9% for T1 tumors, and 11% for patients who refused surgical resection. Five-year lung cancer-specific survival rates were 16%, 23%, and 22%, respectively. Among these untreated patients, median survival was 9 months overall, 13 months for patients with T1 disease, and 14 months for patients who refused surgical resection. Conclusion: Long-term survival with untreated stage I NSCLC is uncommon, and the vast majority of untreated patients die of lung cancer. Given that median survival is only 13 months in patients with T1 disease, surgical resection or other ablative therapies should not be delayed even in patients with small lung cancers.

KW - Early detection

KW - Non-small cell lung cancer

KW - Screening

KW - Survival

UR - http://www.scopus.com/inward/record.url?scp=34447504017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447504017&partnerID=8YFLogxK

U2 - 10.1378/chest.06-3096

DO - 10.1378/chest.06-3096

M3 - Article

C2 - 17505036

AN - SCOPUS:34447504017

VL - 132

SP - 193

EP - 199

JO - Chest

JF - Chest

SN - 0012-3692

IS - 1

ER -